Trials / Completed
CompletedNCT02183922
Microencapsulated Fish Oil or Conjugated Linoleic Acid in Metabolic Syndrome
Hypocaloric Diet With or Without Microencapsulated Fish Oil or Conjugated Linoleic Acid on Oxidative Stress and Cardiovascular Risk Factors in Women With Metabolic Syndrome Genotyped for Polymorphisms in the Genes PPAR Gamma 2 (Pro12Ala) and Adiponectin (G276T)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- Universidade Federal do Rio de Janeiro · Academic / Other
- Sex
- Female
- Age
- 30 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Our aim was to assess the effects of a hypocaloric diet, including diet fruit jelly with microencapsulated fish oil or conjugated linoleic acid or placebo, on anthropometry, body composition, insulin resistance and lipid profile in women with metabolic syndrome and genotype Pro12Pro in the PPAR gamma 2 gene.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | microencapsulated conjugated linoleic acid | The microencapsulated conjugated linoleic acid received light fruit jam with microencapsulated conjugated linoleic acid (3 g/day) during 12 weeks. |
| DIETARY_SUPPLEMENT | microencapsulated fish oil | The microencapsulated fish oil group received light fruit jam with microencapsulated fish oil (3 g/day) during 12 weeks. |
| DIETARY_SUPPLEMENT | light fruit jam | The placebo group received light fruit jam (15 g/day) during 12 weeks. |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2014-07-08
- Last updated
- 2014-07-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02183922. Inclusion in this directory is not an endorsement.